AI assistant
Sending…
Chemours Co — Director's Dealing 2017
Nov 9, 2017
31561_dirs_2017-11-08_ca8e0d78-a90b-414e-bcc7-615b057d3906.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2017-11-06
Reporting Person: Snell E Bryan (President, Titanium Tech)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-06 | Common Stock | M | 11878 | $11.87 | Acquired | 63063 | Direct |
| 2017-11-06 | Common Stock | S | 11878 | $53.25 | Disposed | 51185 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-06 | Stock Option (Right to Buy) | $11.87 | M | 11878 | Disposed | 2020-02-05 | Common Stock (11878) | Direct |
Footnotes
F1: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2017.
F2: Shares were sold in multiple transactions at prices ranging from $53.00 to $53.76.
F3: Includes directly owned shares, unvested restricted stock units and dividend equivalent units.
More from Chemours Co
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3